BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2015
View Archived Issues
Boehringer Ingelheim starts phase I trial of BI-655130
Read More
Angiogenesis biomarkers are associated with adverse pregnancy outcomes in SLE and APL patients
Read More
Astellas Pharma describes prostanoid EP4 antagonists
Read More
Actelion Pharmaceuticals designs CRTH2 antagonists
Read More
Boehringer Ingelheim and Philogen to collaborate on trial of immunotherapy for AML
Read More
New phase II trial explores use of sevuparin in sickle cell disease
Read More
Bio-Path completes cohort 7 of phase Ib trial of Liposomal Grb-2 in AML
Read More
Lilly and Innovent Biologics expand their strategic alliance
Read More
New insights into ADHD
Read More
Acceleron's ACE-083 increases muscle preclinically, enters phase I study
Read More
Myriad Genetics validates pan-cancer genetic test using saliva
Read More
Loss-of-function mutations in TBK1 is associated with FTD and ALS
Read More
aTyr Pharma begins phase Ib/II trial for patients with limb girdle muscular dystrophy 2B
Read More
Takeda Pharmaceutical patents PKC theta inhibitors
Read More
Incyte and Merck & Co. to study the combination of epacadostat with Keytruda
Read More
The Vanderbilt University discloses Mcl-1 inhibitors
Read More
Piramal Enterprises develops retinoid ROR-gammaT antagonists
Read More
Torrent Pharmaceuticals reports MAPK14 inhibitors
Read More
Cinryze receives FDA fast track designation
Read More
Zavante announces formation of new company
Read More
PBI-4050 awarded E.U. orphan drug designation for IPF
Read More
Lassomycin kills M. tuberculosis by a two-fold mechanism
Read More
Sequenom and UKE to profile circulating tumor DNA in CRC
Read More
Novartis makes additional investment in Gamida Cell
Read More
PELI3 shows promise as a biomarker for SS-KCS
Read More
Addex Therapeutics reports efficacy of ADX-71441 in models of alcohol use disorder
Read More
Takeda and UCL partner to discover gene targets for neurodegenerative diseases
Read More